Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 103,400 |
|
|||||
| News | - | ||||||
| Day High | 7.185 | Low High |
|||||
| Day Low | 6.98 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Travere Therapeutics Inc | TVTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.10 | -1.38% | 7.13 | 10:46:05 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 7.12 | 6.98 | 7.185 | 7.23 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,476 | 103,400 | $ 7.10 | $ 733,893 | - | 5.12 - 19.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:46:42 | 1 | $ 7.135 | USD |
Travere Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 535.73M | 76.10M | - | 145.24M | -111.4M | -1.46 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Travere Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TVTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.11 | 7.99 | 7.03 | 7.59 | 961,102 | 0.02 | 0.28% |
| 1 Month | 6.66 | 7.99 | 6.01 | 6.80 | 1,010,347 | 0.47 | 7.06% |
| 3 Months | 7.68 | 8.41 | 5.12 | 6.62 | 1,214,519 | -0.55 | -7.16% |
| 6 Months | 7.81 | 10.27 | 5.12 | 7.79 | 1,285,332 | -0.68 | -8.71% |
| 1 Year | 19.30 | 19.50 | 5.12 | 9.27 | 1,399,565 | -12.17 | -63.06% |
| 3 Years | 14.28 | 31.65 | 5.12 | 16.53 | 1,096,472 | -7.15 | -50.07% |
| 5 Years | 25.15 | 33.0899 | 5.12 | 17.23 | 1,021,380 | -18.02 | -71.65% |
Travere Therapeutics Description
| Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. |
